Prescription stimulant brand name recognition among a national sample of 10‐ to 18‐year‐old youth

OBJECTIVE: The majority of prescription drugs, including prescription stimulants, are marketed using multiple brand names, doses, and formulations. There is limited research on the extent to which individuals correctly identify medication by brand name or packaging, but such identification is important for epidemiological studies especially among youth. Testing the ability of youth to identify medications was one aim of the National Monitoring of Prescription Stimulants Study, which focused on the prevalence of prescription stimulant use among youth. METHODS: Using the entertainment venue intercept method, youth 10 to 18 years of age (n = 11,048) were recruited across 10 metropolitan areas throughout the United States, shown pictures of eight formulations of prescription stimulants, and asked to identify them by name, dosage, and formulation. RESULTS: Overall, 27% of youth reported having seen one of the eight stimulant formulations and between 2% and 70% correctly identified name, dose, and formulation. Youths' reports of having seen and correctly identifying medication increased with age except for Daytrana(®). Specifically, while 2.8% of youth reported using Adderall(®) in the past 30 days, only 71.4% correctly identified it. CONCLUSIONS: These results provide strong evidence of the need for more stringent methods for youth to report drug use.